text:
MAMAMOO Involved In Minor Car Accident On Way To Music Festival
It has been belatedly revealed that girl group MAMAMOO was involved in a minor car accident at 6:40 p.m. on October 13. The group was not able to make it to the 49th Yeongdong Nangye Korean Traditional Music Festival, which had been their destination.
MAMAMOO's agency, RBW, let fans know via their official fan cafe late October 13, saying, "While the accident was minor, we thought going to the hospital was the first priority, so we went to a nearby hospital and [the members] got a checkup. Once we were able to confirm that the members were all okay, we tried to make it to the event, but it was too late."
The agency stated that the MAMAMOO members are all in good health and that there is no need for worry. Closing, the agency apologized for causing worry and for missing the festival.
Source (1)


text:
Pattern # 217: Caron Baby Hoodie
This baby hoodie is ADORABLE! This makes me want to have kids right now. haha What do you think? Is it cute enough for you to make? Oh! And check out the little like / dislike buttons on the bottom of my posts. I just added them because I thought it might be fun!
Picture from Caron Yarn:
Thursday, August 5, 2010
August 5: Caron Baby Hoodie
Posted by Megan at 10:00 AM
2 comments:
- AnonymousAugust 5, 2010 at 10:09 AM
This is so cute!! Makes me want to have another!ReplyDelete
Um, yeah....no. It's adorable and I love kids, but no amount of persuasion could make me want children I have to raise. LOLReplyDelete
Still, this looks like a great quick & simple project to make for a relative's munchkin or for a craft fair.
Subscribe to: Post Comments (Atom)

subset: commoncrawl


text:
I just returned (and yes, detoxed) from the Cornell HR in Hospitality Conference in Las Vegas.
I presented on wage-and-hour issues at the FLSA Unconference, and participated in a roundtable where attendees were able to "ask the attorney" all of their burning legal questions. I also attended a bunch of terrific sessions to gain


text:
26A Aitken Street, GISBORNE 3437 Sold
Secure Investment Opportunity
Presenting a Commercial 1 zoning these two adjoining dwellings on one title, each with their own frontage, present an outstanding opportunity to secure a fruitful and rewarding investment. Boasting high exposure on the busy main street of Gisborne the front facing property, delivers a long-standing tenant and ample OSP. Polished concrete floors, verandah with awning, kitchenette and toilet with separate hand basin are complemented by the existing tenants' quality fit outs. An award-winning spa and wellness centre, comprising four treatment rooms and modern reception space currently provides an annual return of $26,996 + GST and a percentage of outgoings, securely leased till July 2019 with an option for an additional three years. Fronting Heritage Way near parking and lane way access, the rear dwelling includes a large open area with disabled toilet, ideal for a studio or office fitout. Totalling approximately 192m2 and set amongst specialty shops, boutique eateries, major banks and supermarkets, this dynamic opportunity represents a solid investment.


text:
Rauch, Mabel Thompson | Southern Illinois University Special Collections Research Center
Name: Rauch, Mabel Thompson
Historical Note:
Mabel Thompson Rauch was born in Carbondale, Ill., November 30, 1888 to Theodore Wilson and Lovina Rendleman Thompson. The mile-square family farm where she was born is now a part of the campus of Southern Illinois University.
She attended SIU, then spent a year at the School of Music, Belmont College, studying voice. On August 11, 1913, she married James Lee Rauch.
After raising her children, she began a successful career writing about her Southern Illinois heritage. She contributed more than 250 short stories and articles to periodicals, and wrote 2 novels for children.


text: To reduce the environmental, geographical and human impact of a building, Leclercq Associés takes into account the different stages of its life-cycle from design to execution… In this framework, low impact work sites secure the logistics of construction equipment, reduce the number of accidents, limit impacts on people living in the immediate area (noise, dust, vehicle traffic, etc.) and improve the cleanliness of the site. A fresh approach that makes life easier for building companies.


text: I decided to do the foam panels thil the gunwale line and to laminate. After that you can step in the hull and do the other side. Today I did the seams for the second time with putty and put the HD pieces in. Yesterday I glued the missing pieces HD foam on the daggerboard.


text:
2015 toyota Camry Specs
The rub response is due to the fact that it can. With an R&D spending plan asserted to be $1 million each hour, the world's largest car business can afford to bath its mid-size family sedan with financial love, following Chief Executive Officer Akio Toyoda's guileless instruction to "build far better cars." There are 6 various other reasons. Ford, Honda, Hyundai, Mazda, Nissan, as well as Volkswagen all offer exceptional mid-size options to the compulsively withdrawn Camry. In August, Honda loaded its shotgun with excess supply and also charitable incentives to blow up out 51,075 Accords, defeating Camry sales by 7032 devices.
2015 toyota Camry Specs
Toyota Wants to Aficionado ... It Up
So only three years after the last full redesign, Toyota has actually considerably fluffed and buffed the Camry to renew the rate of interest of faithful consumers and to (hopefully) attract fresh recruits. The 2015 edition we drove on the Big Island of Hawaii lives halfway between a regular midcycle facelift as well as a clean-sheet overhaul. Every exterior panel is brand-new other than the roof. Adding 22 area welds in the cowl and around the door apertures improves the rigidity of the unibody. The previous base L model is dead, and also there are extra variations with an "S" in their name to celebrate Toyota's discovery that also Camry purchasers may be captivated by even more assertive driving characteristics. Cost-conscious interiors have been updated with more soft surfaces, better outlining, and modern electronic gear. Chassis systems-- steering, brakes, suspension-- get small changes targeted at far better ride and feel. The one location getting no attention is powertrains: The Camry's 2.5-liter four-cylinder, 3.5-liter V-6, and crossbreed propulsion system-- every one of which are trustworthy and proven, if not amazing-- continue without change.
Two front-fascia layouts attract eyes to this long-ignored model. There's a five-bar treatment for versions with an L in their name as well as a honeycomb maw for those coded S. All relative have subtle hood folds and also upper as well as reduced character folds in their side surfaces. Lamp treatments-- specifically the running-light slashes decorating the reduced front edges-- approach racy. The one little chicanery is an artificial quarter-window stuck into each C-pillar. Ironically, Hyundai as well as Toyota are heading in other designing instructions. The 2015 Hyundai Sonata has backed off some on bold exterior layout just as the Camry molts its uninteresting skin.
Inside, the Camry overtakes the affordable-mid-size-sedan times. The intent is to provide nice-to-touch, user friendly surfaces throughout. Upper trim levels obtain French seams; all cars receive added soft trim, plainly labeled handles and also buttons, and also a rearview camera. Almost the base LEs receive a 4.2-inch TFT display in between the cluster dials for vehicle driver info, navigation guidelines, and advising messages. The listing of offered safety and security equipment currently includes lane-departure caution, automatic brake assist, a blind-spot display with back traffic alert, as well as radar-based energetic cruise ship control. Although you don't have to look to find some recurring shiny, tough, black plastic (there's some at the base of the windscreen, where it triggers glare), the Camry's brand-new interior is a deserving upgrade, especially taking into account the modest rate boosts.
Old folks have dominated the Camry consumer base, yet a minimum of there's a concerted effort right here to welcome them to the information age. The Entune multimedia system consists of a 6.1- or 7.0-inch touch screen with voice acknowledgment, Bluetooth streaming, a USB port, and also an extensive list of applications. By touching the proper icon, you can reset the clock or sync your mobile phone. The top 10-speaker, 586-watt JBL stereo is method too hip for elders thanks to less boominess and boosted frequency balance. The niftiest piece of equipment that's optional in several designs and standard in a few is a nonslip surface area located in the facility console that makes use of Qi innovation to wirelessly reenergize suitable mobile phones. Take that, Honda Accord!
Driving the New(- ish) Camry
Thanks to the more rigid unibody and 30-percent extra undercarpet audio deadening, even the base Camry is a smooth, quiet runner. All front bucket seats have wrapping back-rests and also grippy coverings immune to side slip. Life in back is well free of tire as well as wind sound, and the rear seat accommodates three grownups in comfort. Backrests split and layer even on the hybrid to broaden the roomy trunk. All powertrains are polite and also reasonably well acted though lacking in verve. If passing various other autos gets on your schedule, avoid the 178-hp four-cylinder, as it has a tendency to leave you hanging much also long in the oncoming-traffic lane. The drone that afflicts Toyota Priuses is happily soft in all three Camry hybrid trim levels.
Offer the Camry's engineering group debt for holding weight gain to less than 100 extra pounds by offsetting content enhancements with lighter home window regulatory authorities and also windshield-wiping tools. Streamlining the trunk-hinge mechanism and also combining 2 cargo-floor floor coverings right into a single treatment also conserved a few pounds. We expect velocity and quiting performance to nearly match the outward bound Camry's. In other words, performance suffices ... for your moms and dads. The hands-on change mode won't hold gears at redline, although in S designs it does match revs during downshifts.
Even with somewhat larger wheel tracks, a half-inch gain in the width of the base wheels, and also stiffer base-level front springs, there's no noticeable gain in dealing with to report. The small suspension retune was mainly focused on enhancing the flight top quality over the bumps that are never hard to discover around Toyota's Ann Arbor, Michigan, technical facility. All Camrys ride on all-season radials that prioritize low rolling resistance, high gas mileage, and also great wet and snow grasp over dry-pavement traction. The XSE package, that includes 18-inch wheels and also tires, is like it obtains. Here, the steering effort increases slightly off-center, though additional initiative build and road really feel are tragically absent. While there's more grip than with the 16- and 17-inch wheels as well as body control is reasonable, the front tires howl 'reduce!' when you get frisky on a twisty roadway. Brakes have been enhanced with a new two-stage booster, yet it's adjusted for more pedal travel than we favor for optimal inflection.
Crossbreed consumers can use the new more assertive Camry outside style by choosing the SE version. While they're limited to 17-inch rolling supply, at the very least they benefit from better front-to-rear balance thanks to the weight of the 1.6-kWh battery pack spotted in the trunk. For lots of Camry types, the crossbreed is the clever option thanks to its mixed mileage rating (41 mpg in the LE, 40 in the SE as well as XLE) and velocity that defeats the 2.5-liter four-cylinder.
Toyota has infused a lot of benefits into its most traditional model. The new Camry should stand up well for an additional few years against the mid-size affordable crisis, not to mention the unrelenting crossover attack. The nod that the XSE V-6 version makes in the sports-sedan direction is also motivating. As soon as dedicated clients see as well as feel this brand-new version, it's possible they'll find the cars and truck enthusiast's wavelength as well as look for or require a more significant driving equipment when Toyota navigates to the following complete Camry redesign.


text:
1.5 mile w/u + strides
Target: 5k @2 minutes faster than Tim Rhodes
Actual: MRN 16:59.5; TR 18:59.3
1.5 mile c/d
Total: 6 miles
Yes, you read that correctly. My objective was to beat Tim by two minutes. I beat him by one minute, fifty-nine seconds and eight tenths of a second. I couldn't have scripted a more nail-biting conclusion if I'd tried--except that if I did, obviously I would've amended the ending so that I kicked the last lap about three-tenths faster.
The race began at the conclusion of an already hectic day. I'd worked at RFYL for the morning and most of the afternoon, then headed to school to write my midterm exam. My professor was awesome and agreed to meet me 30 minutes early so that I'd have plenty of time to finish before the race began, but I still couldn't shake the vague nervous feeling that I was running behind schedule. As it turned out, I finished and made it over to MPHS with plenty of time to spare. I warmed up a bit with Paul and Billy--not too much, as there's really no need to do more than a few minutes when it's this warm and humid outside--and we all strategized our respective game plans. Paul hoped to go sub-16, while Billy wanted to break 17 minutes for the first time. I, of course, wanted to beat Tim by two or more minutes, and none of the three of us wanted to be lapped more than once by Jordan. It's good to have goals.
We were told upon our return that the 5k would go off around 7:45, which gave us plenty of time to make some final preparations. Caitlin, Jay and Aaron had showed up to watch, as had a few of my coworkers from RFYL and Tim's oldest son Grant. There may have been 20 other people on the track, but our showdown was the focal point of the evening (at least in my mind). We lined up against the setting sun on the far side of the track, listened to some final instructions, and were off.
First lap, tucked in comfortably behind Paul. Clearly this was the
high point of the race for me.
From the first few strides, I could tell I felt good. Jordan had immediately shot out to the front, but I came through the first lap tucked comfortably behind Paul in 77-point. At that moment I thought to myself that the race might not be too bad, that the heat and humidity wouldn't play as much of a factor as I'd initially feared. I was wrong. I came through the mile in 5:21 feeling decent but not great, but two laps later I would suffer the beginning stages of my implosion as the heat began to take its toll. The wheels were dangerously near coming off, and I felt the lack of workouts and hard running since Nationals catching up with me. Two miles came and went in 10:50, and I was in the hurt tank. I kept reminding myself that my time didn't matter; all that counted was the distance between myself and Tim.
Billy on my heels about halfway through the race.
Speaking of Tim, I caught up to him just a few minutes later and swung around him on the top of the turn. I estimated that lapping him meant I'd put about 90 seconds between us, and now the question was whether I could increase that increment by 30 more seconds in the final three and a half laps. I knew it would have to come from him slowing down, because there simply wasn't anything left in the tank to facilitate me speeding up. I was feeling worse than I had in any 5k in recent memory, and I wasn't even guaranteed to break 17 minutes. Brutal. With one lap to go I tried to feed off the encouragement of Caitlin and Jordan--he, of course, had already finished some time earlier--and kick it in. I saw the clock ticking upward as I ran down the final straightaway and managed to cross just under the 17-minute mark, exhausted and incredibly thirsty. Now there was nothing to do but wait and see what Tim could muster in the final few minutes. As he rounded the final turn, all who were watching knew it was going to be close. He was clearly giving it everything he had and going to the well, determination showing on his face. Still, I couldn't believe it when he crossed the finish line in 18:59, exactly two minutes after me. Only a comparison of the official post-decimal place times afterward confirmed that he had edged me out by a minuscule two-tenths. Unbelievable. Afterwards we shook hands and ran a few cooldown laps together; one of us victorious, one defeated, both relieved to have the battle behind us.
Finishing. Hurt tank.
In hindsight, and not to sound like a sore loser (too much), I believe a few amendments should have been made to the nature of our agreement in order to truly level the playing field. First is the matter of lapped runners. I would say that of the 20 people in the field, I lapped 12. Of the 12, I double lapped 6. Of the 18 lapping incidents, only one person moved out of the way. (Not that I expect them to at this type of meet; I'm just stating the facts.) So, in other words, there were 17 times when I had to step outside my line of motion and add on a small fraction of distance in order to go around someone else. You may say that's just the nature of racing, and I agree with that. But in a scenario when you're racing someone else against a very specific time on the clock, those increments add up. Secondly, I wish there could've been a way for me to start behind Tim and then spend the entire race attempting to reel him in. And by that, I mean a way other than me standing at the starting line looking like a doofus for two minutes after everyone else had taken off. Because, as my heartbreaking final lap in the 10k at Nationals so aptly illustrated, it's much easier to catch someone in the final few meters when they are a visible target in front of you. I didn't have that opportunity tonight.
Overall, objections notwithstanding, this was an absolute blast. I don't necessarily mean the 17 minutes that I was actually racing, because those were brutal, but rather the nature of the friendly wager between myself and Tim. It's great to work for someone who not only shares my appreciation for the sport but is also not afraid to challenge himself and push both of us to be better runners. Plus, it's not exactly like I lose anything by having to take his job for a day. That just means I get to come in late, avoid phone calls from customers, take several two-hour lunches and then sneak out the back when I'm ready to go home. If that's all it takes to keep RFYL running smoothly, then I think I've got it covered.
Tuesday, June 29, 2010
Myers Park All-Comers 5k
1.5 mile w/u + strides


text:
First things first, you can get sick from Sugar with or without the presence of Obesity.
Excessive consumption of Sugar may not manifest itself in your physical appearance (that is why there are people with bad eating habits but are still very petite) but it does not mean they are not or may not suffer the consequences.
We tend to think Fat in foods make us fat, in as much as that is true, sugar is the number one leading cause of Obesity.
Your cells need the Sugar glucose to help your organs function. Most foods contain Sucrose, a type of Sugar that is found naturally in Fruits and Vegetables and added in processed foods . This sugar cannot be used up by the body so it will need to be converted to glucose in the liver first. Your liver can only do so much in such little time, If you overwhelm it with added sugar,majority will be stored as fat and not used up as glucose. This process, if done repetitively will lead to excess weight gain and risks of lifestyle diseases.
In fact a high reduction in consumption of processed sugar intake has been equated to:
- Reduced diabetes
- Reduced heart diseases
- Reduced weight gain
- Reduced risks of certain cancers etc
So what should you do?
- Avoid foods with lots of added sugar i.e sodas, fruit juices, sweets etc they do not aid your body nutritionally at all.
- Eat your fresh fruits in moderation and avoid juicing your fruits too much, it gets rid of fiber that aids in regulating sugar that is released to your system. You can get fat from eating lots of sugary fruits at once
- Eat lots of vegetables
How much sugar will you take out of your diet today?


text: YES. If I got your question right, then I think you are referring to the kind of hurt you experience when the love you are giving was not reciprocated by the person to whom you gave it to. I do think that love is a risk, and that no one has ever loved and has never been hurt in the course of it. No relationship is perfect, and no two people are 100% compatible. Hence, there will come a time when you will be hurt by the arguments, the decisions, and the demands and expectations brought about by being in a relationship. I think it is high time we stop feeding ourselves with the ideal kind of love and start looking at real life scenarios. There will always be heartbreaks. There will always be compromises. But what matters most is how you use these things as basis of your growth.


text:
To long
This has been one of those times of year that you make plans to do something you love to do and unfortunately work gets in the way. This has been the busiest new year I have experienced since I start working in the field I am in. So I can't make any promises that I will be able to continue my days of encouragement. But, I'm not going to beat myself up over it, that is just life. So my bit of encouragement for today is, Max! my pet rabbit. I never thought I would have a pet rabbit, but I do and he is sooooooo sweet.


text:
Life Community is a Christian Non Denominational church located in Mt. Pleasant, South Carolina. Our focus, our main interest here is pursuing the life God has given each of us as we journey with one another.
In the Bible's New Testament there is a statement delivered by the Apostle Paul. He says: Now there remains three things, faith, hope and love. The greatest of these is love. Loving is not a word that always describes who we are…but together we are learning to love better.
So, we set out to explore, what does it mean to love God, and what does it mean to love each other (even people we may not like)? If we were to love, really love, what would it look like?
It would probably look like this: rather than condemning others we would build bridges to friendships so we could know them and they could know us. Life can be that simple; to know others and to be known by others.
Now, in order to do that kind of work we have to create a community of people who believe in this pursuit. We are not all alike, no church is. We at times disagree, but in the end, we come to realize that God's love can radically change ones worldview which in turn changes ones life.
Jesus noted that our being who we were created to be hinges on the action of love. He said we'd be far better off loving God with all of our being and loving our neighbor as we love ourself. We can't do this by ourselves, so we practice leaning into God and depending on one another. Some days it works, and those are days we grow to appreciate our interdependence on each other. Those are days we feel most alive.
There are other articles you'll find here under the headings of Conversation, Connection, and Community which will give you a broader look into the heart of Life Community Church. If you have any questions or want to dig deeper into what you've read here please join us on Sunday at 10:15 or you can reach me via phone call or text at 843-754-9361 or through email at email@example.com
Thank you for taking a look at Who We Are
Mike Cooke, Pastor
Sunday mornings...
We gather at 10:15am on Sunday mornings at The Musical Theater Center/Once Upon a Ballet at 547 Longpoint Rd. Suite 105. It's in the same business park as Duff Fitness, Two Blokes Brewery & Jackson Soccer Developlment/Elite Futsal Charleston.
We hope you'll join us this Sunday for coffee, conversation, connection and community.


text:
by Cody Allison
UncategorizedDecember 17, 20190 comments
There are not many areas of the law in which medical proof is so necessary to be able to make a successful claim. Below is a useful article on this subject. Remember, if you need help in making a long-term disability claim, we are here to help.
HEALTH LAW AND ETHICS ERISA Litigation and Physician Autonomy
Peter D. Jacobson, JD, MPH
Scott D. Pomfret, JD
THE FEDERAL EMPLOYEE RETIREMENT INCOME SECURITY ACT (ERISA) looms like a colossus over the man- aged care environment. Originally enacted to regulate employer-sponsored pension plans, the statute also covers health care benefits established by self-insured employers (with few exceptions, such as for governmental employees). According to recent Department of Labor estimates, ERISA applies to approximately 125 million US citizens.1 ERISA has created a regulatory vacuum by preempting state regulation of managed care organizations (MCOs) and drastically limiting state medical liability lawsuits against MCOs, while providing minimal federal regulation in their place. 2-4 For physicians, ERISA preemption has indirectly caused courts to favor MCOs' cost containment initiatives over traditional notions of physician autonomy. 5 The treatment a physician recommends is vulnerable to a managed care utilization management process largely unconstrained by state regulation or liability law, inevitably resulting in reduced physician autonomy. The consequences of ERISA preemption lie at the heart of proposed congressional patients' rights legislation that would restore the primacy of the patient-physician relationship and permit state legal challenges to cost containment programs. At issue is control over physicians' clinical decisions and the ability to challenge improperly operated cost containment programs. Because ERISA plays a vital role in the relationship between physicians and MCOs, it is important for physicians to understand what ERISA is, how it operates, and how it influences clinical decision making and physician autonomy in the managed care era. In this article, we outline ERISA's major provisions, analyze trends in ERISA litigation applicable to physicians, and conclude by discussing the policy implications and
significance of these trends for physician autonomy. AN ERISA PRIMER Overview Congress enacted ERISA in 1974 primarily to regulate pension plans, but it also included health benefit plans within its scope. 6 ERISA's goals are to establish uniform national standards, safeguard employee benefits from loss or abuse, and encourage employers to offer those benefits. To achieve these objectives, ERISA imposes strict requirements on pension plan administrators for reporting and disclosure, 7 participation and vesting, 8 funding, 9 and performance of fiduciary obligations. 10 ERISA does not mandate that employers offer benefit plans, but provides a structure for national uni-
formity of administration once such plans are extended. Only a few of these requirements apply to health benefit plans, in part because Congress did not pursue the impli-
cations of regulating both pension and health benefit plans under 1 statute. Nor could Congress have anticipated the dominance of the managed care model. As a result, ERISA provides almost no federal regulation of health plans. Nevertheless, ERISA has 3 provisions that directly affect physician autonomy: ERISA's preemption clause, its limited remedial scheme, and its fiduciary duty obligation. Author Affiliations: School of Public Health, University of Michigan, Ann Arbor
(Mr Jacobson) and Ropes and Gray, Boston, Mass (Mr Pomfret). Corresponding Author: Peter D. Jacobson, JD, MPH, School of Public Health, Uni-versity of Michigan, 109 Observatory, Ann Arbor, MI 48109-2029 (e-mail: firstname.lastname@example.com). Health Law and Ethics Section Editors: Lawrence O. Gostin, JD, the Georgetown/ Johns Hopkins University Program in Law and Public Health, Washington, DC, and Baltimore, Md; Helene M. Cole, MD, Contributing Editor, JAMA.
The Employee Retirement Income Security Act (ERISA), enacted in 1974 to regulate pension and health benefit plans, is a complex statute that dominates the managed care environment. Physicians must understand ERISA's role in the relationship between themselves and managed care organizations (MCOs), including how it can influence clinical decision making and physician autonomy. This article describes ERISA's central provisions and how ERISA influences health care delivery in MCOs. We analyze ERISA litigation trends in 4 areas: professional liability, utilization management, state legislative initiatives, and compensation arrangements. This analysis demonstrates how courts have interpreted ERISA to limit physician autonomy and subordinate clinical decision making to MCOs' cost containment decisions. Physicians should support efforts to amend ERISA, thus allowing greater state regulatory oversight of MCOs and permitting courts to hold MCOs accountable for their role in medical decision making.
JAMA. 2000;283:921-926 www.jama.com ©2000 American Medical Association. All rights reserved. JAMA, February 16, 2000—Vol 283, No. 921
ERISA's Preemption Clause Traditionally, states are responsible for regulating health care delivery, and litigation against health care providers is resolved under state law. Medical liability lawsuits are rarely heard in federal courts. ERISA alters the traditional approach by preempting state law, which means that state laws purporting to regulate health plans may not be enforced in any court. 11 In this context, state laws include legislation and regulations, such as those mandating particular benefit coverage, and most medical liability actions targeting MCOs. Courts have interpreted the preemption clause broadly to prevent enforcement of state laws ranging from laws protecting the patient-physician relationship to litigation challenging how cost containment initiatives are implemented. The courts have held that Congress intended such broad preemption of state law to allow a multistate employer to offer a single, nationally consistent plan to all its workers without the cost and inconvenience of complying with contradictory state regulations, legislation, or litigation. National uniformity conforms with congressional intent to keep the costs of administering an employee benefit plan (EBP) low to encourage employers to offer health care coverage. 12 In assessing whether a particular state law is prohibited, courts look sequentially to each of the 3 parts of the preemption provision. First, courts must decide whether the state law "relates to" an EBP. 13 In doing so, courts consider whether the challenged law burdens the administration of plan benefits or has only a remote impact on them. Courts generally hold that ERISA preempts state laws that bind employers or plan administrators to particular benefit choices or that preclude the uniform administration of an EBP. 14 For example, a state lawsuit challenging a benefit determination, such as
an MCO's denial of additional hospital coverage, "relates to" a health plan because that challenge would require the court to interpret the plan's benefits, hence binding the administrator to certain actions. But laws with only a remote or incidental effect on plan administration, such as a surcharge on hospital services, may not "relate to" the EBP.
A law is not preempted merely because it "relates to" a plan. Courts must also interpret 2 qualifying provisions, the savings clause and the deemer clause. ERISA's savings clause provides that laws regulating the business of insurance, even if they "relate to" a managed care plan, will not be preempted. This allows states to continue to enforce state laws governing the business of insurance by saving state regulation of health insurance, such as solvency requirements, from preemption. In turn, the deemer clause qualifies the savings clause. The deemer clause prevents states from deeming (or characterizing) an ERISA-covered plan as the business of insurance.
States may not characterize a self-funded plan as an insurer to circumvent the effect of the "relates to" clause. As an example of how these terms interact, consider a state law mandating certain health insurance benefits. That law "relates to" an ERISA plan since it would involve the structure of plan benefits. Even though the legislation would be
saved from preemption insofar as it regulates EBPs that purchase traditional insurance policies, it would still be preempted if, for example, a state attempted to apply the statute to a self-funded EBP. Under the deemer clause, a self-funded EBP cannot be an insurer. ERISA's Limited Remedies Although much state litigation is preempted, ERISA provides some relief for injuries to health plan participants through its civil enforcement scheme. A plan participant or beneficiary may bring a civil action against an administrator who fails to comply with a request for information about the plan, to recover claimed benefits, to enforce rights under the terms of the plan, or to clarify rights to future benefits. 15 A plan participant may also bring suit against a plan fiduciary who breaches any fiduciary duties and may seek to enjoin practices that violate ERISA or the terms of the plan. Even if victorious, a plan participant can usually only recover the amount of the benefits that should have been provided, as well as certain incidentals such as attorneys' fees. This is a decidedly more limited remedy than what is usually available under state law, through which the patient might be able
to recover damages for any economic losses, non-economic damages for pain and suffering, and possibly punitive damages (especially in cases alleging bad faith insurance denial). 16 Take, for example, a challenge to an improperly denied benefit filed in state court. If the MCO successfully invokes preemption, the plaintiff will be forced to sue instead under ERISA's limited civil enforcement scheme. Effectively, this insulates the MCO from exposure to monetary damages, except for what it would have paid (the amount of the denied benefit) in the first place. Fiduciary Duties ERISA imposes a fiduciary duty on those who make discretionary decisions on behalf of the EBP. A fiduciary must discharge his/her discretionary functions "solely in the interest of the participants and beneficiaries" of the plan. 17 In many, but not all cases, 18 courts have held that MCOs are subject to this fiduciary duty when making certain decisions, such as reviewing the appropriateness of a physician's treatment recommendations. 19 On the other hand, MCOs and employers are not considered fiduciaries for establishing or changing the terms of the plan. Thus, the fiduciary duty extends only to decisions made once the plan is in place. 20,21 Employers must provide whatever health benefits they promise but need not offer plans at all and can change what they offer af-
ter giving plan beneficiaries proper notice. In exercising the fiduciary duty, an obvious problem is that the clinical needs of one patient may conflict with the
MCO's economic interests. Increasingly, disappointed plan participants have sued for breach of fiduciary duty, often challenging the denial of physician-prescribed benefits, especially when there is a potential conflict of interest. 22
ERISA LITIGATION AND PHYSICIAN AUTONOMY 922 JAMA, February 16, 2000—Vol 283, No. 7
©2000 American Medical Association. All rights reserved.
To determine whether an MCO breached its fiduciary duty when denying plan benefits (ie, that the denial is not solely in the interest of the participant), courts use different levels of scrutiny based on the amount of discretion granted to the MCO under the EBP. Generally, courts are very deferential, upholding the plan administrator as long as the decision was not arbitrary and capricious. 23,24 In most cases, courts have equated compliance with the terms of the EBP as, by definition, acting "in the interests" of the plan participant. In this sense, the court limits its review to ensuring that the MCO reasonably comported with the terms of the EBP. 25 As a result, MCOs retain power vis-a-vis physicians by controlling the interpretation of EBP terms (including medical necessity). But in a case from which the plan profits directly from the denial, the potential conflict of interest must be considered a factor in deciding whether there was an abuse of the fiduciary's discretion.
26 RECENT CASE TRENDS MCO Malpractice Liability
For many years, courts have monitored quality of care through medical liability lawsuits. Originally, physicians were the targets of such suits, then hospitals were added, and now MCOs have been held liable under state tort law. When a patient receives care under a health plan not governed by ERISA (as when a person buys his/her own health
insurance), MCOs have been held directly liable for their own actions, such as the failure to maintain safe and adequate facilities, select and retain competent physicians, oversee all patient care within the institution, and ensure quality care. 26 Managed care organizations can also be held vicariously (indirectly) liable for malpractice committed by physicians who are independent contractors. The primary factors affecting whether a court will impose vicarious liability include the amount of influence the MCO has over the clinical decision, patients' perceptions of the relation ship between the physician and the MCO, and the manner in which the health plan is marketed. Managed care organizations operating in contexts other than ERISA may also be subject to state consumer protection or bad faith insurance laws for improper processing of claims that results in delayed or denied care. 16 In non-ERISA cases, courts are essentially following the pattern of establishing liability that was applied to hospitals beginning in the 1960s. 28 Managed care organizations covered by ERISA operate under different rules. ERISA preempts many state law claims alleging that the MCO's denial or delay in care caused an adverse medical outcome. Those types of lawsuits may be brought in federal court as actions under ERISA's civil enforcement scheme, but the limited remedies available effectively insulate MCOs from liability and, therefore, accountability for these medical outcomes. Liability may be
borne instead entirely by physicians. The practical effect is that MCOs often control resource allocation, but physicians (and patients) bear the costs when resource allocation decisions produce adverse outcomes. In these cases, the patient's only remedy is to sue the physician, regardless of how much influence over the clinical decision the physician actually exercised. Courts have not been consistent in deciding whether all or merely some state law claims against MCOs will be preempted. Until recently, led by early Supreme Court doctrine, lower federal courts have interpreted the phrase "relates to" very broadly, preempting most state law tort suits challenging health plan innovations and medical decisions. For example, courts generally have held that challenges to delayed or denied care relate to an EBP and are preempted, 29 including litigation alleging that the structure of the EBP was responsible for poor medical outcomes. But in New York State Conference of Blue Cross and Blue Shield Plans v Travelers Insurance Co, 30 the Supreme Court permitted New York State to impose a tax on all insurers except Blue Cross and Blue Shield, reasoning that a uniform tax only tangentially relates to ERISA plan administration. This decision signaled a scaling back on the breadth of preemption. After this decision, courts have been less vigorous in finding ERISA preemption. Narrowing preemption has inspired other related changes. The most important change is that courts have erected a critical distinction between state tort law challenges to the technical quality of care (ie, liability claims for substandard clinical care) and state law challenges to the quantity of care (involving improper plan benefit decisions). The latter must be brought in federal court subject to ERISA's limited remedies; the former would be heard in state court. In practice, the quantity/quality distinction may signal a nascent trend toward holding MCOs accountable at least in some circumstances, especially, if courts strain to characterize a dispute as involving quality. By way of example, the court in Bauman v US Healthcare, Inc 31 recently held that the defendant's policy of discharging a newborn within 24 hours without adequately considering the medical appropriateness in a given case could be challenged in state court as substandard quality of care. As their liability expands,
MCOs may begin to reconsider the ways in which they review clinical decisions, as the United Healthcare decision 32 signaled recently by shifting greater clinical authority back to physicians. It is one thing to deny treatment when potential liability rests with the treating physician, but it is an other to deny the claim when the organization might also be held responsible. Consider, for example, state litigation seeking to hold an MCO indirectly liable for the actions of an affiliated physician. Because substandard care is litigation about the quality of care and not the quantity of benefits, the case will probably be heard in state court. And because state courts assess liability based in part on the amount of influence the MCO exerts over clinical decision making, MCOs may seek to avoid liability by loosening their control below the threshold required by state law. The result is increased physician autonomy. While this result is what we anticipate, greater liability exposure could alternatively lead an MCO to protect itself by exerting stricter oversight of clinical decisions. Exactly how MCOs respond will need to be studied. Preemption is not the only area in which this trend toward judicial reconsideration may be emerging. In recent years, many lawsuits charging MCO misconduct that resulted in adverse outcomes from delayed or denied care have been cast as breaches of fiduciary duty under ERISA. 33 No patient has yet recovered a judgment in such a case 34; but to the extent such suits are successful, MCOs might be less likely to second-guess clinical decision making. To date, the decisions have been inconsistent and no truly coherent doctrine has yet emerged. Most courts have explicitly refused to be the agents of a major overhaul of ERISA doctrine, preferring to leave such a role in the legislative arena. 5 Utilization Management A central aspect of the managed care environment is the emergence of new organizational forms, including utilization management processes, which have mixed clinical and financial functions. Managed care organizations rely heavily on utilization management techniques, such as preauthorization for high-cost medical interventions, to reduce costs. The more courts uphold utilization management decisions, the less control the treating physician has over the clinical encounter. In state cases for which ERISA does not apply, courts have held generally that physicians and MCOs may share liability for bad outcomes. 35,36 By contrast, ERISA preemption clearly shields MCOs from liability in state courts for utilization management decisions, even when these are arguably medical and not merely administrative in nature. So far, federal courts have uniformly held that utilization management decisions relate to benefit plans and are preempted, regardless of whether medical care recommended by the treating physician is denied. For instance, in Danca v. Private Health Care Systems Inc, 37 the court supported the prevailing view that a utilization review dispute was pre-empted by ERISA because it is part of the process used to assess a benefit dispute. 38 And in Corcoran v United Health Care Inc, 39 the court concluded that United's utilization management program, whose denial of hospital care resulted in the death of a fetus, made medical decisions in the context of determining benefits. Accordingly, the court preempted Corcoran's lawsuit under ERISA. By holding that the administrative aspect of the utilization management process trumps the medical aspect (ie, that it is more a quantity than a quality decision), the federal courts, through ERISA, pro-
vide wide latitude for health care plans to control costs, at the possible expense of both individual access to health care services and the treating physician's clinical autonomy. State Legislative Initiatives As part of the backlash against managed care, many state legislatures have tried to safeguard physician autonomy. This legislation has ranged from prohibiting gag clauses to comprehensive reforms designed to limit the primacy of cost containment strategies. In many instances, courts have ruled that these laws are preempted by ERISA, although the decisions are by no means uniform. Such rulings have essentially negated state legislative attempts to restore physician
autonomy and have reinforced health plan control over clinical decisions. The most extensive attempt to regulate MCOs is the Texas statute 40 requiring an external appeals process for health care denials and allowing subscribers to sue the MCO for poor quality of health care. A federal district court recently upheld the right to sue, based on the quality/quantity distinction, yet overturned the external grievance process as preempted by ERISA. 41 Although the case is on appeal, that the court preempted the external review process as a law "relating to" an EBP is an indication of the ERISA-created hurdles facing state laws that try to bolster clinical autonomy. Just as troublesome, the current uncertainty in ERISA litigation makes it difficult, if not impossible, to predict which state laws will be preempted. As an example, courts have split on whether any willing provider laws are preempted by ERISA. 42,43 Any willing provider laws would require MCOs to contract with any provider willing to meet the MCO's established criteria and are intended to preserve patient choice of physician. Compensation Arrangements Another important cost containment mechanism used by MCOs is to provide financial incentives to plan physicians to restrain costs. For instance, salary withholds and bonuses are used as compensation incentives for limiting referrals to specialists and other high-cost procedures. No court has yet ruled that these financial incentives violate public policy, though some non-ERISA cases have permitted challenges to be tried before a jury. 44 ERISA does not regulate how MCOs create incentive structures to motivate contracting physicians' compliance with cost containment measures. More importantly, ERISA preemption may prevent states from trying to regulate such compensation and incentive arrangements through tort law or legislation. A typical case is
Lancaster v Kaiser Foundation Health Plan of Mid-Atlantic States Inc, 45 in which the court held that the plaintiff 's state law claim alleging negligence in establishing and operating an incentive program that encouraged physicians not to prescribe certain expensive tests and not to refer to specialists, was preempted by ERISA. The plain-
tiff claimed that this program was a substantial factor in her physicians' failure to diagnose her brain tumor for 5 1⁄2 years until it had invaded 40% of her brain. The court characterized the establishment and operation of this incentive scheme as an administrative decision affecting the provision of benefits and therefore dismissed the claim as preempted. Not all courts have agreed. 46 A more recent case perhaps presages a different direction based on breach of fiduciary duties (with, of course, the corresponding limit on remedies under ERISA). In Herdrich v Pegram, 47 the court held that a patient could sue for breach of fiduciary duty based on an allegation that the nature of incentive arrangements between the MCO and the physicians caused her to be deprived of proper medical care and that the MCO reaped economic gain from this deprivation. Even though the Herdrich court specifically noted that the existence of economic incentives would not automatically be tantamount to a breach of fiduciary duty, this case is a potentially significant extension of the rationale advanced in non-ERISA cases. If read broadly and followed by other courts, this case could augur an attack on the underlying financial incentives at the core of managed care, perhaps by seeking to enjoin their use. 47 However, Herdrich may represent a legal theory that is viable only in an extreme case in which "a fiduciary jettisons his responsibility to the physical well being of the beneficiaries in favor of loyalty to his own fi-
nancial interests," 46 and the Supreme Court has agreed to review the decision.
ERISA has played an important role in facilitating, and perhaps stimulating, the development of managed care. But this undeniable policy benefit has come at a high cost to some individual plan subscribers and to physicians. From a policy perspective, ERISA has created a regulatory vacuum in which states cannot act and there is no comparable federal regulatory mechanism. From a legal perspective, ERISA has essentially insulated MCOs from liability by blocking state courts from resolving litigation challenging managed care practices. From a clinical perspective, ERISA has facilitated reductions in physician autonomy relative to health plan influence over clinical decisions. Policy Consequences This analysis suggests several consequences of importance to physicians. First, the effect of judicial interpretations of ERISA is to subordinate physician autonomy and the patient physician relationship to managed care cost containment goals. Implicitly, ERISA reinforces the status quo of the health care delivery market and hence managed care's current market domination. Second, perceiving themselves bound by ERISA, courts do not champion either physician autonomy or the patient-
physician relationship. Courts that once protected physician autonomy, are no longer doing so. 49 Judges repeatedly suggest that complaints against managed care should be taken to the legislative branches of government rather than to the courts. Since state legislative initiatives are often barred by ERISA preemption, Congress appears to be physicians' best hope for change or relief. As of this writing, congressional action to amend the preemption provision (so that state legislatures and courts may act with fewer constraints) or to create new federal regulations similar to recent state initiatives appears to be unlikely. During the 1999 session, the House of Representatives enacted a bill that would permit patients to sue MCOs for damages in state courts, but the Senate bill does not contain a right-to-sue provision. Although House and Senate conferees have been meeting to reconcile the 2 bills, the prospects for enactment are slight, in part because the House conferees are largely opposed to the right-to-sue provision. Regardless, physicians should continue to support attempts to remove ERISA preemption. Even though treating physicians would remain accountable, MCOs should also be held accountable for both financial decisions that affect clinical treatment and for their implicit role in making medical decisions. Physicians should not be left in the untenable position of being entirely responsible for cost containment provisions over which they have almost no control. By exposing MCOs to similar liability considerations, MCOs
will not be able to influence medical decisions with impunity, which may enhance physician autonomy. Short of eliminating ERISA preemption, Congress could also amend ERISA by expanding on the available remedies. Consistent with the goal of maintaining national uniformity, Congress could retain preemption but allow individuals to sue for monetary damages in federal court for an ERISA violation. Congress could also direct the US Department of Labor (as the appropriate regulatory agency) to develop regulations that would more effectively protect the patient-physician relationship. For instance, regulations might address patients' rights to notice of a denial of care and to an external grievance panel. Physician Autonomy An assumption animating this article is that deference to physician autonomy is a desirable goal for better patient care. To some, that proposition may not be self-evident. After all, public concern with rising health care costs and perceived harms from overtreatment in the fee-for-service era led
directly to managed care's cost containment innovations and concomitant restrictions on physician autonomy as public policy objectives. Indeed, constraints on physician autonomy predate the effects of ERISA litigation. 50 Thus, one scenario suggests that if Congress removes ERISA preemption and helps restore physician autonomy, man aged care's cost containment goals may be difficult to achieve. This outcome seems unlikely given the current policy environment. Another possible scenario is that MCOs might respond to eliminating ERISA preemption by imposing more aggressive utilization management controls, ironically reducing physician autonomy below what it is under current financial incentives. Yet there is no indication that MCOs are eager to accept the additional liability consequences that may result from greater control over clinical decisions. No matter whether Congress changes ERISA preemption or expands ERISA's limited remedies, the tensions among physicians, MCOs, and patients will not be resolved easily.
©2000 American Medical Association. All rights reserved.
February 16, 2000—Vol 283, No. 7
Even if there are some downsides to physician autonomy, patient care ultimately depends on the treating physician's ability to maintain patient trust while balancing patient demands for high-quality care with the MCO's legitimate cost containment efforts. In truth, these cost containment programs are needed corrections to an unsustainable fee-for-service system, and many physicians have worked effectively to mediate managed care's constraints. Yet, inevitably, some patients will not be well served by this system. Either there will be undue delay in arranging health care, or benefits will be denied that should have been provided. In those situations, holding MCOs legally accountable provides incentives for better health care plan administration. ERISA preemption simply goes too far in removing the liability threat
for improper undertreatment.
Support for this article was provided by an Investigator Award in Health Policy Research from the Robert Wood Johnson Foundation, Princeton, NJ. Acknowledgments:
We thank Stephen Modell, MD, David Hyman, MD, JD, and Edward Goldman, JD, for comments on a previous draft.
Hearings Before the Senate Committee on Labor, and Human Resources . 105th
Congress, 2nd session (1998) (testimony of Meredith Miller, Deputy Assistant Sec-
retary, Pension and Welfare Benefits Administration).
Gostin LO. What's wrong with the ERISA vacuum? employers' freedom to limit
health care coverage provided by risk retention plans. JAMA . 1993;269:2527-2532.
3. Mariner WK. State regulation of managed care and the Employee Retirement
Income Security Act. N Engl J Med. 1996;335:1986-1989.
4. Chirba-Martin MA, Brennan TA. The critical role of ERISA in state health re-
form. Health Aff (Millwood) . 1994;13:142-156.
5. Jacobson PD. Legal challenges to managed care cost containment initiatives:
an initial assessment. Health Aff (Millwood) . 1999;18:69-85.6.
Senate Subcommittee on Labor of the Committee on Labor and Public Welfare.
Legislative History of the Employee Retirement Income Security Act of 1974.
Washington, DC: US Government Printing Office; 1976:3456.
7. Employee Retirement Income Security Act of 1974,29 USCA §1021-1031 (1999).
8. Employee Retirement Income Security Act of 1974, 29 USCA §1051-1061 (1999).
9. Employee Retirement Income Security Act of 1974, 29 USCA §1081-1086 (1999).
10. Employee Retirement Income Security Act of 1974, 29 USCA §1101-1114
11. Nealy v US Healthcare Inc , 711 NE2d 621 (NY 1999).
12. Jordan KA. Travelers Insurance: new support for the argument to restrain ERISA
preemption. Yale J Regulation . 1996;13:255-336.
13. Jacobson PD, Pomfret SD. Form, function, and managed care torts: achiev-
ing fairness and equity in ERISA jurisprudence. Houston Law Rev
. 1998;35:985- 1078.
Moreno v Health Partners Health Plan
, 4 F Supp 2d 888 (D Ariz 1998).
15. Employee Retirement
Income Security Act of 1974, 29 USCA §1132 (1999).
McEvoy v Group Health Cooperative of Eau Claire, 570 NW2d 397 (Wis 1997).
17. Employee Retirement Income Security Act of 1974, 29 USCA §1104 (a)(1)
18. Kyle Railways Inc v Pacific Administration Services , 990 F2d 513 (9th Cir 1993).
19. Reilly v Blue Cross and Blue Shield United of Wisconsin, 846 F2d 416 (7th
Cir 1988).
Curtiss-Wright Corp v Schoonejongen, 115 SCt 1223, 1228 (1995).
21. Maltz v Aetna Health Plans of New York, 114 F3d 9, 12 (2d Cir 1997).
22. Firestone Tire & Rubber Co v Bruch, 489 US 101 (1989).
23. McGraw v Prudential Insurance Co , 1998 WL 96849 (10th Cir 1998).
24. Morreim EH. Benefits decisions in ERISA plans: diminishing deference to
fiduciaries and an emerging problem for provider-sponsored organizations.
University of Tennessee Law Rev. 1998;65:511-553.
25. England v John Alden Life Insurance Co, 846 F Supp 798, 801 (WD Mo 1994).
26. Killian v Healthsource Provident Administrators Inc, 152 F3d 514 (6th Cir
27. Boyd v Albert Einstein Medical Center, 547 A2d 1229 (Pa Super 1988).
28. Petrovich v Share Health Plan of Illinois Inc , 188 Ill 2d 17 (1999).
29. Andrews-Clarke v Travelers Insurance Co, 1997 WL 677932 (D Mass 1997).
30. New York State Conference of Blue Cross and Blue Shield Plans v Travelers
Insurance Co, 514 US 645 (1995).
31. Bauman v US Healthcare Inc, 193 F3d 151 (3rd Cir 1999).
32. Freudenheim M. Big HMO to give decisions on care back to doctors.
New York Times. November 9, 1999:A1.
33. Ince v Healthsource Arkansas Inc, 1997 WL 591117 (ED Ark 1997).
34. Pomfret SD. Emerging theories of liability for utilization review under ERISA health plans.
Tort Insurance Law J. 1998;34:131-166.
35. Wilson v State of California, 271 Cal Rptr 876 (Calif 1990).
36. Long v Great West Life & Annuity Insurance Co
, 957 P2d 823 (Wyo 1998).
37. Danca v Private Health Care Systems Inc, WL 552604 (1st Cir 1999).
38. Tolton v American Biodyne Inc, 48 F3d 937 (6th Cir 1995).
39. Corcoran v United Health Care Inc, F2d 1321 (5th Cir. 1992).
40. Tex Civ Prac & Rem Code Ann, The Health Care Liability Act, §§ 88.001-88.003.
41. Corporate Health Ins Inc v Texas Department of Insurance, 12 F Supp 2d 597
(SD Tex 1998).
Blue Cross and Blue Shield v St Mary's Hospital, 426 SE2d 117 (1993).
43. Texas Pharmacy Association v Prudential Insurance Co of America, 105 F3d
1035, 1039 (5th Cir 1997).
44. Paul v Humana Medical Plan Inc, 682 So2d 1119 (Fla 1996).
45. Lancaster v Kaiser Foundation Health Plan of Mid-Atlantic States Inc, WL
174182 (ED Va 1997).
46. Oulette v The Christ Hospital, 942-154F Supp 1160 (SD Ohio 1996).
47. Herdrich v Pegram, F3d 362 (7th Cir 1998).
48. Herdrich v Pegram, 170 F3d 683 (7th Cir 1999), dissenting opinion.
49. Hall MA. Institutional control of physician behavior: legal barriers to health care cost containment.
University of Pennsylvania Law Review. 1998;137:431-536.
50. Light D, Levine S. The changing character of the medical profession: a theo-
retical overview. Milbank Q . 1998;66(suppl 2):10-3
Latest Posts
by Cody Allison
New ERISA Suit filed against Salesforce
If you believe you have been wrongfully denied your ERISA, or non-ERISA, long-term disability benefits, give us a call for a free lawyer consultation. You...
New ERISA Suit filed against Salesforce
UncategorizedJune 4, 2020
by Cody Allison
COVID-19 and High Risk Individuals Under ERISA
If you believe you have been wrongfully denied your ERISA, or non-ERISA, long-term disability benefits, give us a call for a free lawyer consultation. You...
by Cody Allison
Significant New ERISA Case on Statute of Limitations
If you believe you have been wrongfully denied your ERISA, or non-ERISA, long-term disability benefits, give us a call for a free lawyer consultation. You...


text:
Food & Drink
5 Best Food and Kitchen Hacks and Tips You Need Now
It's always nice to gather new and helpful tips in the kitchen and to learn about the foods we love. Check out this group of a little bit of this and that. Some tips, info and hacks. Copy and have them on hand when needed or for a reference. See you back here soon with more. Gathering them up!


text:
I have installed BuddyPress on a single site http://www.our-minecraft.com and am using the Blogs MU theme. (WP 3.2.1)
I started a new user to test the settings and when I responded to the email link I was taken to a page with a log in link in the page that did not work. It's hard to replicate this as the activation process has been completed on that user.


text:
Ralph Arellanes, Racist Executive Director, NM LULAC?
Posted by Pete | Posted in News | Posted on 21-03-2016
Man, this guy Arellances fired a hate filled letter to the University of New Mexico President in today's Albuquerque Journal, March 21 2016, over the firing of the women's basketball coach Yvonne Sanchez. It sounds like LULAC is something akin to a white version of the KKK. In the letter he said, "I don't like that our tax dollars go to a bunch of lame White coaches, White Athletic Director and frankly, a White UNM President who doesn't give a rats ass about our community of New Mexico. You and your white cronies must be held accountable and Fired. I will be speaking to the press about this today and calling for your removal once and for all"!……Sounds like a very decent sort, huh? I really don't know why he did not say what was really on his mind instead of beating around the bush…..Which is kind of you white folks get out and let us good guys run the show. This letter really make me wonder about the objective of this organization. It certainly does not promote the Hispanic people and most of the Hispanics I know will most probably take exception to the wording of this letter also. I do not know Mr. Arellanes, but with his attitude I don't think I want to know him. I don't think Coach Sanchez will appreciate the letter either.


text:
Written in an easy–to–follow style , this textbook provides an introduction to this exciting subject with chapters covering natural and synthetic polymers, colloids, surfactants, biological soft matter and liquid crystals and the many and varied applications of these materials. It has been newly edited and has chapters with updated coverage of recent aspects of polymer science. A series of questions and answers is also provided at the end of each chapter. The book contains a new chapter on biological soft matter, which adds significantly to the discussion of proteins, DNA and lipid membranes in the previous edition.
The book will appeal to students of polymer, biomaterial, colloid, surface and interface science. Experienced researchers in the field will also find this a good introductory text for revising their knowledge of the basics.
Reviews of the First Edition
"A timely and concise textbook on "soft matter" suitable for both undergraduate students and researchers."
Advanced Materials
"It is well written in an easy–to–follow style and deals with some quite complex topics by good use of analogy and comparison."
Chemistry in Britain
Preface to the First Edition.
1. Introduction.
1.2 Intermolecular Interactions.
1.3 Structural Organization.
1.4 Dynamics.
1.5 Phase Transitions.
1.6 Order Parameters.
1.7 Scaling Laws.
1.8 Polydispersity.
1.9 Experimental Techniques for Investigating Soft Matter.
1.10 Computer Simulation.
Further Reading.
2. Polymers.
2.1 Introduction.
2.2 Synthesis.
2.3 Polymer Chain Conformation.
2.4 Characterization.
2.5 Polymer Solutions.
2.6 Amorphous Polymers.
2.7 Crystalline Polymers.
2.8 Plastics.
2.9 Rubber.
2.10 Fibres.
2.11 Polymer Blends and Block Copolymers.
2.12 Dendrimers and Hyperbranched Polymers.
2.13 Polyelectrolytes.
2.14 Electronic and Opto–Electronic Polymers.
Further Reading.
3. Colloids.
3.1 Introduction.
3.2 Types of Colloids.
3.3 Forces between Colloidal Particles.
3.4 Characterization of Colloids.
3.5 Charge Stabilization.
3.6 Steric Stabilization.
3.7 Effect of Polymers on Colloid Stability.
3.8 Kinetic Properties.
3.9 Sols.
3.10 Gels.
3.11 Clays.
3.12 Foams.
3.13 Emulsions.
3.14 Food Colloids.
3.15 Concentrated Colloidal Dispersions.
Further Reading.
4. Amphiphiles.
4.1 Introduction.
4.2 Types of Amphiphile.
4.3 Surface Activity.
4.4 Surfactant Monolayers and Langmuir–Blodgett Films.
4.5 Adsorption at Solid Interfaces.
4.6 Micellization and the Critical Micelle Concentration.
4.7 Detergency.
4.8 Solubilization in Micelles.
4.9 Interfacial Curvature and Its Relationship to Molecular Structure.
4.10 Liquid Crystal Phases at High Concentrations.
4.11 Membranes.
4.12 Templated Structures.
Further Reading.
5. Liquid Crystals.
5.1 Introduction.
5.2 Types of Liquid Crystals.
5.3 Characteristics of Liquid Crystal Phases.
5.4 Identification of Liquid Crystal Phases.
5.5 Orientational Order.
5.6 Elastic Properties.
5.7 Phase Transitions in Liquid Crystals.
Further Reading.
6. Biological Soft Matter Science.
6.1 Introduction.
6.2 Lipid Membranes.
6.4 Proteins.
6.5 Polysaccharides and Glycoproteins.
6.6 Macromolecular Assemblies.
Further Reading.
Numerical Solutions to Questions.


text:
Kicking off MWC 2017, LG unveiled the G6, the first major flagship smartphone of 2017. The Korean company had a particularly terrible 2016 with the modular approach that it took with the G5 getting huge thumbs down from consumers.
This year, LG has decided not to experiment with its flagship handset for 2017. Instead, it has filled it to the brim with features and cutting-edge technology. The handset does use Qualcomm's yesteryear Snapdragon 821 chipset, but don't rule it out just on that basis. There is more to the G6 than its chipset. Here ar e5 things about the G6 that you probably don't know, but should.
Read: LG G6 Hands On
No more boot loops
LG devices are known for suddenly bootlooping after a year or two of use. The issue has been affecting almost all flagship LG devices since the last three years and includes some of its popular devices like the V10, G4, G5, Nexus 5X, and V20. Most of the time, the issue occurs when the device is already out of warranty, and since LG does not officially acknowledge the problem, customers end up paying for the repair job out of their pocket.
Thanks to the Galaxy Note 7 fiasco last year, the whole of smartphone industry has taken a look at their QC/QA testing process and made it more stringent. LG too has laid great emphasis on the reliability of the components used in the G6 this time around. While there is no official confirmation from LG here and it's too early to tell, be rest assured that the G6 will not suffer from any bootlooping issues like previous LG devices.
Bye Bye IR Blaster
Last year, the G5 was among the very few flagship handsets to feature an IR blaster. While not popular in the US and European market, IR blaster is incredibly handy to have on a smartphone. On previous LG devices with an IR blaster like the G5, G4, and V10, one could easily control all home appliances like TV, music player, etc. around them by using LG's Quick Remote app.
However, with the G6, LG has given the IR blaster a boot. This means that you will not be able to use the phone to control other electronic appliances around you.
Google Assistant
Up until now, Google's Pixel handsets were the only one in the market to ship with Google Assistant out of the box. That changes with the G6's unveiling which now becomes the second handset in the market to offer Google Assistant. Google's new personal assistant is not perfect, but with Google at the helm of things, its just a matter of time and a few updates before Assistant becomes a key factor for anyone buying an Android phone.
Until Google opens up Assistant to other Android devices, the G6 and Pixel will remain the only two devices to feature the company's new smarter and more conversational assistant.
IP68 Certified
Not to miss out on the water-resistant trend that all flagship handsets this year will follow, LG has also ensured that the G6 features an IP68 certification. This means that the handset is dust-resistant and can also survive being dunked in 1.5m depth of water for up to 30mins without any issues. However, as is the case with water-resistant phones, LG's standard 1-year warranty does not include any kind of water damage repairs. So, if you somehow still end up water damaging your G6, you will have to shell out money from your pocket to get it fixed.
Free Unlimited Storage Space on Google Photos
Like with the Google Pixel, LG is also offering free unlimited storage space on Google Photos with the G6. This means that any photo or video — even the ones recorded in 4K — that you upload to the service will not count against your existing quota of storage space on your Google account. This might not seem like a big deal but considering how good the rear shooter on the G6 is, you will automatically start clicking more photos with the handset. This will also let you delete photos from your G6 once they are backed up to the cloud thereby ensuring that you don't run out of internal storage space on the device.
Wireless Charging
The LG G6 variants sold in the United States will come with wirlewss charging built-in. However, the variant of the handset sold in Asia and other regions will give the technology a pass.
64GB Storage
While the US variants of the G6 will come with wireless charging, they will only come with a paltry 32GB of storage. In comparison, the Asian, Korean and CIS variants of the handset will come with a more standard 64GB of storage space.
So, while there is not much that can be done about the G6 coming with a Snapdragon 821 chipset, it is still a fine handset by all means that packs some impressive piece of technology. Do you think you will buy the G6? Or are you disappointed with the handset?


text:
Contact Info
Air Evac Lifeteam 115
Rhonda Dean
482 N Bosley
Santo, Tx 76472
Phone: 940-327-7767
Fax: 817-887-5192
Visit our Website
Hours of Operation24 hours a day; 7 days a week
About Us
AirMedCare Network is the largest air ambulance membership network in the business of saving lives, and giving our members peace of mind during a medical emergency for over 30 years. We now have over 2.6 million members in 38 states including Alaska & Hawaii and over 320 bases including Eastland, Texas. Being a member you pay nothing if you are ever flown and membership covers entire household. If you are not a member the average cost of a flight is $26k and most insurances pay minimal. Crews include pilot, nurse & medic with at least 3 years of trauma experience available 24 hours a day; 7 days a week. Thank you for supporting and keeping our aircraft in your communities. Don't Wait Until It's Too Late!


text:
'As the days begin, I pick up a brush, mix some colours and start making the first mark on a canvas - without knowing where it will lead. My work is very much like an autobiography - layers of feeling about the past, the present and the future. I paint instead of writing a diary.
'For this exhibition, I visited St Ives and the surrounding area in January and March. I really enjoyed walking on the SW Coast Path. My souvenirs from those visits were, the moment when I was looking at 'Cape Cornwall' through the cottage window, the coming and going of the 'Silent Waves - the Cycle of Life' and the moment when I was standing at the bottom of Kenidjack Valley with no one else around.
'I was born and raised in Japan and gained a BA in Fine Art from Joshibi University of Art and Design in Tokyo. At the time, I was more interested in photography than painting. But after moving to New York, I realised that painting was my main interest. I took a drawing class at The Art Students League and started painting more seriously.
'Since I moved to England in 1989, I've been exhibiting at various galleries and venues. Also my work is in the BBC "Your Paintings – the UK's publicly-owned oil paintings" project since my work is in Hampshire County Council's collections.'


text:
Bridget Walton is a paralegal in the Firm's Intellectual Property Practice Group with more than 20 years of experience in various departments of the Litigation Practice Group.
An integral member of the Intellectual Property Practice Group, Bridget assists attorneys with patent prosecution and docket management. She regularly assists in the preparation and filing of case materials necessary for patent prosecution. Bridget also aids attorneys with the renewal and maintenance of patents.
Bridget routinely prepares all types of supporting documents for client execution, such as declarations, assignments and power of attorney forms. She works closely with clients and foreign counsels to coordinate renewals and maintenance of patents worldwide. Bridget also assists attorneys with prior art preparation and filings.
Practice Areas
- Southern Illinois University at Carbondale (B.A., magna cum laude, 1995)
Legal Background
- Litigation paralegal, Thompson Coburn LLP (1995-1998)


text:
The British designer celebrates fifteen years in fashion with a short movie that tells the dream of 15-year-old Matthew, a magic story that ends suddenly when he wakes up.
But to me it looks like in real world the dream of Matthew Williamson actually came true, and celebrating 15 years from the start of his career with a short like this one prooves that.
The video itself is a result of the work of a dream team too:
Starring: Siena Miller, Poppy Delevingne and Andrea Riseborough and eight ballerinas from the Royal Ballet
Choreography: Wayne McGregor
Directed by: Tell No One
Thanks to my friend Zlatina for sharing this piece of content with me.
Thursday, 15 November 2012
Subscribe to: Posts (Atom)


text:
Toccoa Falls College
Located in northern Georgia about 100 miles from the sprawling metropolis of Atlanta, Toccoa Falls College is a liberal arts institution with a religious orientation. About 800 undergraduate students study here, the majority of whom concentrate in fields of religion or education, or a combination of the two. Interesting student groups on campus include mime and puppet teams.


text:
Samphran Elephant Theme Show (one day trip)
Travel Information
Travel Rate
วันที่ 1
Every day Afternoon: 12.00 A.M. To 18.00 P.M.
Samphran Elephant Theme Show
Afternoon: 12.00 A.M. To 18.00 P.M.
- Pick up from hotel depart for Samphran Elephant Ground & Zoo.
- Crocodile Wrestling Show:Samphran Elephant Ground & Zoo also offers spectacular shows of Crocodile wrestling between man and crocodiles. It has been acclaimed to have one of the cleanest and most impressive public crocodile displays in the world. (CITES 1991)
- Elephant Theme Show:for the first time ever an elephant show complete with dramatic sounds and narration. Be entertained by demonstrations of elephants at work, playing football dancing and at play. See for yourself how elephants are rounded up and used during battles in ancient Siam, where Siamese and Burmese armies dressed in full battle gear once used elephants.
- At the end of tour will be visit to local product store.
Tour includes:
- Transportation / All admission fee as in the itinerary / English Speaking Guide
Tour Excluded:
- Personal expenses / Option Tour
- Not included 7% of Vat
General Terms and Conditions
Child Charge: under 1 year old free of charge (NON SEAT), 100c.m.up charge same as adult price.
Payment Terms: After the conferencing from employees
Others: No refund in case of natural disaster or force majeure such as sick or miss the van for late


text:
Would you recommend this product?No reviews yet
Hey guys, I'm one of the founders. Our goal is to let you deploy code to the cloud really simply, without worrying about servers and infrastructure. You write your code, a small config describing the stack you want (i.e. Fedora and Python), and the interface into your code (i.e. the functions you want exposed.) You type `stackhut deploy`, and it's live as a API that can be called through a POST request or RPC. In the backend, we spin up a new Docker container for every request to your service, so it can scale horizontally with no side effects. For instance, here is a service that which compresses a PDF: http://stackhut.com/#/u/lanthias... Here is the code that was `stackhut deploy`d: https://github.com/lanthias/pdf-... If you sign up for beta we'd love to walk you through deploying a service (we currently support Python and JS). Would love all thoughts and feedback here, or you can ping me at email@example.com if you'd like to chat. Cheers!
Upvote (3)Share
@leoanthias @stackhut Are you supporting code written in any other languages yet?
Added to my All Things API collection: http://www.producthunt.com/@anuj...
Upvote (2)Share
Hi Leo, That's look pretty cool, very simple and easy! Few questions: Is it just for one-time-running like requests (like converting formats or getting calc math equation)? Do I have any sandbox or some global running env, or is it all stateless? Can you give some more examples for using it? Good luck!
@shemag8 Thanks for your feedback Shem. Right now we are focusing on run-once immutable events, because that's the stuff we always needed to spin up servers for. This means we aren't handling state yet -- but it's something we are going to be doing soon (a shared state between all your apps probably). We're really open to change all this depending on what users want -- including adding long-running services which more resemble a traditional server. For more examples, http://stackhut.com/#/services are a few services already on the platform. You can play with them all on their respective pages (all of them are open source). https://stackhut.readthedocs.org... will run you through installing the platform and building your own services. It would be super helpful to know what burning pain we could solve. What would your dream product, that you would use everyday, look like?
@leoanthias @shemag8 First- the painfull thing I thing already solved- the easy interface for publishing my API and debug it from remote. Second thing I might want is some analytics about the usage of my api, looks like it's missing, am I right?
@shemag8 Hey Shem. We currently have the first bit solved (FYI we are going to be offering stateful, persistent services in the next few days.) We don't have any public analytics available for APIs, but can definitely build it. Are you envisioning building a public API which will be consumed by your users, or building an internal API to be part of your infrastructure? Cheers


text:
TRIACONTANOL the powder chemical for plants growing by hydroponics or by nutrient film techniques (NFT)
Triacontanol is a powerful plant growth regulator that can improve growth rates of plants grown by hydroponics or nutrient film techniques. It can make bigger and bushier plants with higher growth rates and larger crop yields.
Triacontanol application can be either as a foliar spray or as an additive to the general feed tanks.
Hydroponics growers are familiar with a range of additives to their growing systems, but here the powder chemical gives an opportunity of closer regulation and customisation according to plant growth required.
The chemical triacontanol can be used as simple additive or in combination with Gibberellic acid which is also offered by ourselves. See Gibb Acid GA3
There are numerous publications indicating the benefit of triacontanol in improving plants growth and yield allied to its activity as a photosynthesis enhancer.
The combination of high nutrient levels and supra-optimal environmental conditions can produce remarkable increases in yields in a range of crops.
The chemical Triacontanol, is used in commercial horticulture to improve plant growth worldwide. As a photosynthesis enhancer it increases plant growth in combination with a number of other plant growth regulating actions.
Plant growth regulator Triacontanol used on plants
Increase plant or crop yield.
Enhance photosynthesis and plant metabolism.
Induce the production of flower buds and flowering.
Allow the production of bigger leaves, and bigger root system.
Increase cell growth in roots, and used to produce thicker foliage and flowers.
Production of robust plants more resistant to disease and pathogens.
Increase basal branching of rosette plants, and allow more basal breaks.
Improve establishment and growth of young plants produced from cuttings, seed or plugs.
Used to help plants suffering nutrient and growth deficiencies.
Triaboost adds additional triacontanol to standard Hydro Fertiliser Brands to improve crops and yields. Boost your growth with Triaboost! Feeding with Triaboost is very easy and you will get great results.
For hydroponic feeding add a tube of Triaboost to your bottle of feed or direct to your resevoir to make a 250 litre tank.
Triaboost for Hydroponic tanks.
x1 tube (10ml) Triaboost / 250 litres resevoir + your Hydroponic feed.
1ml Triaboost / 25 litres dilution. or 10ml Triaboost / 250 litres.
Triaboost is supplies as 10ml tube. A mixture of fully dissolved triacontanol and micro nutrients. None of these products will register on a conductivity meter. So feed at your standard conductivity or fertiliser dilutions.
Leading Hydroponic Nutrient Brands are often made up to 250 litres. A 10ml Triaboost tube matches this volume. Safely mixes and will not cause any sedimentation, Will not form 'gypsum' and mixes safely with fertilisers that contain soluble Silicon.
Many of our customers report noticeable increased growth and yields from their plants from simply adding Triaboost into their growing regime.


text: HEAVY METAL VINTAGE SIGN (SUBLIMATION PROCESS) MEASURES 30" X 24" WITH HOLES IN EACH CORNER FOR EASY MOUNTING WEIGHS APOX. 6 POUNDS. THIS IS A SPECIAL ORDER SIGN, NORMALLY TAKES 2-3 WEEKS FOR DELIVERY. The price for shipping on this product is calculated for the 48 contiguous United States, Alaska, Hawaii and all other countries will require additional shipping cost. We do not have the option to add any charges to your credit card, so once we have an accurate shipping cost we will contact you and explain how to cover the additional shipping cost, If at that point you feel it is too much, we can send a refund to your credit card for the full amount of your purchace. Thanks, Clark, Old Time Signs; GREAT APPEAL FOR MANY R.R. COLLECTORS


text:
Virtual Library
Start Your Search
G. Bescher
Author of
ORAL 06 - Next Generation Sequencing and Testing Implications (ID 90)
- Event: WCLC 2015
- Type: Oral Session
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 1
- Moderators:G. De Lima Lopes, V. Miller
- Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 1a-1f
ORAL06.05 - Molecular Tumor Board (MTB) in Non-Small Cell Lung Cancers (NSCLC) to Optimize Targeted Therapies: 4 Years' Experience at Gustave Roussy (ID 2563)
10:45 - 12:15 | Author(s): G. Bescher
- Abstract
- Presentation
- Slides
Molecular biology has changed the treatment of advanced NSCLC, leading to many small subgroups of patients (pts) eligible for targeted therapies, many of them being not approved. Since 2010 we created a monthly MTB dedicated to NSCLC pts with potential driving molecular abnormalitie(s). MTB includes expert physicians from the lung tumor board and phase I unit, radiation therapists, researchers, geneticists, pathologists and biologists. A medical report summarizes the findings and treatment recommendations for each pts. We report 4 years of activity of MTB at Gustave-Roussy.
All consecutive files discussed in MTB for a NSCLC were reviewed. MTB included pts with at least one molecular alteration based on a 75 gene panel (NGS analysis and FISH for ALK, HER2, MET, FGFR1, ROS1 and RET). Tumor and pts characteristics were collected as well as treatments. Pts outcome was calculated from the MTB date. Kaplan-Meier methods, and Cox proportional hazards models were used for survival analysis, adjusting for sex, histology, smoking status, metastasis at diagnosis, number of line(s) before MTB.
502 files were discussed between 02/2010 and 09/2014. Median age was 60 yrs (25–88 yrs), 53% were male, 86% Caucasian, 26% never-smokers, and 93% had PS ≤1. Initial clinical stage was III-IV in 417 pts (84%) and 79%/10%/11% were adenocarcinomas/squamous cell carcinomas/others NSCLC. Median number of treatment-lines before MTB was 1 (0-10), 86% were previously treated by a platinum-based chemotherapy regimen, 17% in a therapeutic trial, and median time from diagnosis to MTB was 5 months. Biopsy for Molecular Analysis (MoA) mostly came from CT guided biopsies (62%), surgery (21%) or endoscopy (16%). Biopsy was repeated in 19% of pts to get enough material for MoA. The MoA results were ALK rearrangement in 11%, exon 18/19/20/21 EGFR mutation (mut) in 2/14/4/7% respectively, KRAS mut in 32%, PI3KCA mut in 3%, BRAF mut in 5%, HER2 mut (Exon 20) in 2%, HER2 amplification in 2%, FGFR1 amplification in 3%, MET amplification in 3% and other rare mutations in 27%. MTB recommended a targeted therapy in 344 pts (68%) either within clinical trials (57%), EMA approved therapy (23%), an off label drug (9%), or an expanded access program (11%). 162pts (47%) actually received the recommended therapy, 141 (41%) did not and 41 (12%) might receive it at the time of progression. Median follow-up was 24 months (1-24; follow-up censored after 24 months). Median OS was 13.1 months [95%CI: 8.8; 18.2] for non-oriented pts, and 14.3 months [11.5; 16.7] for oriented pts (p=0.39). We observed a significant difference between EGFR/ALK/ROS1 mutated/rearranged pts (median 23.8 months) vs. pts with KRAS (8.6 months) or others mutations (11.1 months) or non-oriented pts (13.1 m; p=0.0008, HR=0.56, 1.15 and 0.97 respectively compared to non-oriented).
MTB is feasible in daily practice with treatment recommendations in a majority of NSCLC pts (68%), enrichment in clinical trials or expanded access programs, and limitation of off-label drugs use. Benefit on survival for all oriented pts has to be clarified based on the type of molecular abnormality. Update results will be presented at the meeting.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.


text:
Pete has lived in the Flathead Valley for over 17 years. After living in Colorado and Utah, his passion for the outdoors finally drew him to Montana. It didn't take him long to realize this was a special place, and he settled down to make this area his home. Years of experience in the service industry has given Pete the ability to work well with clients and connect with people quickly. An avid skier, mountain biker, and fly fisherman, Pete's enthusiasm for outdoor recreating has taken him all over the valley and has given him a unique and expert knowledge of the area. Whatever your passion is, Pete would love to show you what makes this area special and help you find your piece of it. To contact Pete call: 406.270.5908.
Planning to build in Whitefish? Follow the International Energy Code
City of Whitefish Fall Newsletter 2018
In the fall of 2014, the State of Montana adopted the 2012 International Energy Conservation Code. All certified cities such as Whitefish followed with local adoption shortly after.
The purpose of this code is to provide a standard for all new construction while using scientific information to build a more energy efficient home.
The code establishes minimum standards for insulation, as well as ventilation requirements. This information is required on building plans and examined during plan review to ensure code compliance.
When designing a new home, owners should check with their contractor to ensure that the energy code is being followed. Often the decision is made to exceed the minimum standard and build the most energy efficient home possible.
For more information on the energy code, contact the Montana Department of Environmental Quality (MT DEQ) at 406-444-6697 or find them online at http://www.deq.mt.gov/energy/default.mcpx
Commercial property sales increase in the Flathead Valley
Commercial property sales were strong in 2018, with 26 sales in the north Flathead Valley including Whitefish and Columbia Falls. Sales included office buildings, business opportunities, commercial buildings and raw land.
Below is a sampling of commercial properties available today. Call 406.862.9000 for more information and a tour of these commercial properties.
Bargain on Big Mountain
By Tristan Scott, Flathead Beacon 10-26-18
Ski and snowboard films are hitting the silver screen and the first snowfall of winter is right around the corner, marking the start of ski season. And while various mountains and resorts appeal to skiers and snowboarders for a range of reasons, including snow, location and terrain, the cost of a day on the hill is a ubiquitous consideration.
If affordability and minimal crowds top your list of winter-getaway demands, Whitefish Mountain Resort on Big Mountain remains one of the preeminent destinations in North America.
Plan your visit to Whitefish
Outside or indoors, there are so many ways to fill your days with things to do in and around Whitefish.
Glacier National Park is only 25 miles from Whitefish. Whitefish Mountain Resort ski and summer area is just minutes away. Play on the water, stroll the 40+ miles of the Whitefish Trail, take in a professional theatre performance or live music, or stop in at a gallery to learn about the local arts scene.
Award-winning cuisine, world-class wine selections and great service—all reasons Whitefish exceeds dining expectations and offering nearly every variety of style and fare. Many chefs pride themselves on their use of fresh, local and organic vegetables, fruits, and meats. Each dining experience is an opportunity to savor the local flavor.
A stroll through the covered sidewalks of Central Avenue or through the historic Railway District reveals a broad variety of locally-owned shops and galleries. Discover fine artisan jewelry made with Montana-native gems or a new pair of hiking boots for the next adventure. Locally-roasted coffee beans, homemade skin care, hand-dyed yarn and huckleberry products make great gifts for those back home.


text:
by Henri Roca, MD, Clinical Functional Medicine Specialist Being gluten-free hasn't been that hard and it has been so worth it. Yet my sensitivity to gluten came as a surprise. Why?
by Henri Roca, MD Holiday celebrating can be a challenge if you are gluten-free and still in the place of craving gluten. Here are some tips to make it easier:
It negatively affects more than one third of all Americans, many of whom don't even know it. Diseases like inflammatory bowel disease, lupus, anemia, cancer, rheumatoid arthritis, and multiple sclerosis are just a few conditions that may be caused by something found in most Americans' diets.
by Henri Roca, MD, Clinical Functional Medicine Specialist November 12, 2013 the American Heart Association and the American College of Cardiology issued a new guideline that is a boon to those who make and sell the statin class of cholesterol lowering medications.
by Amy O'Donnell, DC Many people visit the chiropractor and simply get adjusted. Yet there is so much more that a chiropractor can add to your overall wellness especially if you experience aches and pain.
by Maria Rickert Hong, Certified Holistic Nutrition Counselor A lot of people are going gluten-free these days – is this just a fad or a real and growing trend?
by Henri Roca, MD, Integrative Functional Medicine Specialist I've received many questions over the years asking about unsettling effects when taking medication or natural products. First of all, both can have untoward effects though it is exceedingly rare that supplements result in permanent or dangerous unfavorable effects.